A 10-year retrospective cohort study of ruxolitinib and association with non-melanoma skin cancer in polycythemia vera and myelofibrosis patients

Clinical trials report occurrence of non-melanoma skin cancers (NMSC) with ruxolitinib in polycythemia (PV) or myelofibrosis (MF) patients, however the level of risk and effect of covariates are not known in the real-world setting.

Source: Journal of the American Academy of Dermatology - October 10, 2021 Category: Dermatology Authors: John Q. Lin, Shirley Q. Li, Shufeng Li, Eileen F. Kiamanesh, Sumaira Z. Aasi, Bernice Y. Kwong, Anne Lynn S. Chang Source Type: research